GMTN GMTN Gander Mountain beats by $0.57 (6.64 ) Reports Q4 (Jan) earnings of $1.45 per share, $0.57 better than the Reuters Estimates consensus of $0.88; revenues rose 17.5% year/year to $280.8 mln vs the $277.4 mln consensus ALSO MATK $0.07 better than the Reuters Estimates consensus of $0.12; revenues fell 5.4% year/year to $62.9 mln vs the $59.6 mln consensus Martek Biosci on call says Q2 should be record sales qtr
and three upgrades on matk Martek Biosci upgraded to Buy from Neutral at First Albany- on Solid Quarter and Guidance (MATK) 30.53 Martek Biosci tgt raised to $44 at Needham following results and strong margins (MATK) 30.53 : Needham raises their tgt on MATK to $44 from $40 following Q1 results. Firm said the co had already told them that rev would be strong in the qtr, but margins significantly exceeded their expectations. Firm thinks that these quarterly results and guidance for Q2 support their thesis that the co's troubles of 2005 are now behind it, and it is poised for strong growth and steady execution in 2006. Firm also thinks it is now clear that 2006 ests have been too conservative, and they expect to see numbers going up. Reits Buy. DA Davidson upgrades matk to Underperform
والله لو يسكر نهاية الاسبوع على هالسعر واكثر رايح يكون فرصة حلوة على الويكلي .... يعطيك الف عافية تيريليوني
mashallah bo ebraheem as always you are the star of this board your stock is on the high which is very good
thanx for every things salam bo ali this is what we need at least at this time thanx for every things bo ali we appreciate ur help yours
